Biohaven (BHVN) Exchange Rate Effect (2022 - 2026)
Biohaven's (BHVN) quarterly Exchange Rate Effect came in at $16000.0 in Q1 2026, down 30.43% year-on-year from $23000.0 in Q1 2025, and up 14.29% quarter-over-quarter from $14000.0 in Q3 2025.
Biohaven (BHVN) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Biohaven has disclosed Exchange Rate Effect across 5 years of filings, most recently posting $16000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $16000.0, down 30.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10000.0 (down 109.62% YoY), and the FY2025 annual result was -$3000.0, down 104.0% from the prior year.
- Exchange Rate Effect came in at $16000.0 for Q1 2026 at Biohaven, up from $14000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $429000.0 in Q4 2022 to a low of -$310000.0 in Q4 2023.
- The 5-year median for Exchange Rate Effect is $4000.0 (2024), against an average of $1666.7.
- Peak annual rise in Exchange Rate Effect reached 483.33% in 2025, while the deepest fall reached 471.43% in 2025.
- Biohaven's Exchange Rate Effect stood at $429000.0 in 2022, then tumbled by 172.26% to -$310000.0 in 2023, then soared by 128.39% to $88000.0 in 2024, then tumbled by 84.09% to $14000.0 in 2025, then climbed by 14.29% to $16000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $16000.0 (Q1 2026), $14000.0 (Q3 2025), and -$40000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | -40,000.00 |
| Jun 30, 2025 | -40,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | -310,000.00 |
| Dec 31, 2023 | -310,000.00 |
| Sep 30, 2023 | -40,000.00 |
| Sep 30, 2023 | -40,000.00 |
| Jun 30, 2023 | -162,000.00 |
| Jun 30, 2023 | -162,000.00 |